Nothing really new except these two points which I didn't know before.
Currently 2-3 healthcare R&D companies actively considering Mix&Go™
• Short term revenue opportunities as R&D companies take less time on approval processes
Whats everyone think. A real question I would love to ask Geoff, is if the global markets dont hold up due to Greece et al, and we go into GFC Mark II, how does he see this affecting our potential to sign new deals, as we all know our potential customers will need to scale back their investments.
How many companies does he think will definitely not be able to invest in M&G if GFC2 eventuates.
13 minutes to open, here is to a great day.
Ann: 2011 AGM Presentation , page-2
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.9¢ | 2.7¢ | $17.68K | 634.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 541015 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 4693635 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |